American Oncology Network Shines with 15 Research Presentations

American Oncology Network Showcases Research Excellence at ASCO 2025
American Oncology Network (AON), one of the nation’s rapidly expanding community oncology networks, recently revealed that 15 research abstracts authored by its physicians and leaders have received acceptance for presentation at the prestigious American Society of Clinical Oncology (ASCO) Quality Care Symposium 2025. Held in Chicago, this year’s theme, Driving Solutions, Implementing Change, aimed to push the boundaries of oncology practice and enhance patient care.
Highlights from the Symposium Presentations
AON is set to discuss a diverse range of topics at the symposium, including the profound implications of the Inflation Reduction Act’s impact on oncology care costs. This particular study (Abstract #2) offers a crucial look at how new legislative frameworks are redefining payment structures in oncology.
Key Topics of Discussion
Among the featured research topics presented by AON include:
- Navigating New Norms: The influence of the Inflation Reduction Act on Part D expenditures in oncology care (Abstract #2).
- The Shrinking Dollar: A critical look at how inflation has impacted reimbursement for oncology physicians (Abstract #21).
- Unpacking Cost of Care: Factors contributing to the total cost of oncology treatment episodes (Abstract #22).
- The Impacts of Medicare Biosimilar Policies: A study exploring the effects of reimbursement policies on oncology practice (Abstract #25).
- Rethinking Infusion Staffing Metrics: Addressing the complexity of modern hematology-oncology therapies (Abstract #62).
- Balancing Case Mix Risk: An analysis of how cancer type mix influences savings in cost of care models (Abstract #82).
- Assessing Episode Groupers: Understanding their impact on cost and quality in oncology care (Abstract #90).
- The Geography of Deprivation in Oncology Care: Discussing access issues related to geography (Abstract #234).
- Clinical Adjusters in the EOM: How they can be derived from claims instead of practice-reported data (Abstract #87).
- Clinical Outcomes with Pembrolizumab: Evaluating weight-based dosing in the Enhancing Oncology Model (Abstract #27).
- Health Equity in Oncology: How AON is addressing disparities in cancer care to ensure better access and outcomes for all patients.
Commitment to Innovation and Collaborative Practice
“It is a privilege to share our research with peers at the ASCO Quality Care Symposium,” remarked Puneeth Indurlal, MD, AON’s senior vice president of strategic operations. “Attendance at the ASCO symposium fosters collaboration, innovation, and the advancement of clinical oncology, reflecting our dedication to improving cancer care through evidence-based practices.”
Dr. Stephen “Fred” Divers, AON’s chief medical officer, echoed these sentiments, stating that the results from AON’s studies grant valuable insights which can enhance oncology practices today and in the future. He emphasized that collaborations with partners like Thyme Care have enabled the network to utilize real-world clinical data effectively.
Acknowledging Talents Across AON's Network
“Featuring so many AON physicians and leaders at the ASCO Quality Care Symposium speaks volumes about our network's talent,” stated Todd Schonherz, AON’s chief executive officer. “We take pride in our culture of innovation and continuous learning, which empowers us to contribute significantly to the advancement of oncology.”
For more details about the American Oncology Network and its initiatives, interested individuals can visit AONcology.com.
About American Oncology Network
American Oncology Network (AON) is an alliance of dedicated physicians and healthcare leaders striving to sustain the long-term success and viability of community oncology. Founded in 2018, AON has expanded rapidly, now representing over 300 providers practicing across 20 states. The organization is committed to innovative healthcare solutions through its physician-led model, focusing on value-based care that enhances patient outcomes while reducing costs. AON strives to offer its providers comprehensive support, integrated services, and management expertise, allowing them to focus on delivering high-quality care to every patient, promoting health equity to tackle disparities in cancer care.
Frequently Asked Questions
What is the ASCO Quality Care Symposium?
The ASCO Quality Care Symposium is a key event focused on improving cancer care through innovative practices and collaborative research presentations.
How many research abstracts did AON present?
AON presented a total of 15 research abstracts at the symposium, showcasing various impactful studies.
What themes are being discussed at the symposium?
This year's theme is Driving Solutions, Implementing Change, which focuses on improving oncology practices and patient outcomes.
Who are the key speakers from AON?
Key contributors from AON include Puneeth Indurlal, MD, Dr. Stephen “Fred” Divers, and Todd Schonherz who discussed the importance of their research.
What does AON stand for?
AON stands for the American Oncology Network, an organization dedicated to advancing community oncology through research and innovation.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.